New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the ...

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...

Vermont has the second lowest state fatality rate in the US (147.2 per 100K; Hawaii 112.9/100K). Mississippi (464.7/100K) and ...

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Interim surveillance network data showed lower hospitalization rates following the availability of prevention products.

New multi-center US study finds RSV co-infection in children under two is not linked to worse clinical outcomes, challenging ...

Recent data shows that most infants are receiving RSV vaccination in the US, but rates vary by race and birth month.

"Who are you putting the Apple Watch on? The toddler?" -- David Mandell, ScD, of the University of Pennsylvania School of ...

There was a significant drop in the number of babies hospitalized with RSV this year; a positive news story that can be ...